Press Releases China Pharma Holdings, Inc.

Equities

CPHI

US16941T3023

Delayed Nyse Other stock markets 19:06:36 15/05/2024 BST			5-day change	1st Jan Change
0.32 ^USD	-1.99%		+1.62%	-47.11%

04-01	China Pharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-23	China Pharma to Conduct 1-For-5 Reverse Stock Split; Shares Fall After-Hours	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CHINA PHARMA HOLDINGS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	20/04/23	AQ
CHINA PHARMA HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	30/03/23	AQ
China Pharma : Current Report - Form 8-K	29/03/23	PU
CHINA PHARMA HOLDINGS, INC. : Other Events (form 8-K)	29/03/23	AQ
CHINA PHARMA HOLDINGS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	24/02/23	AQ
CHINA PHARMA HOLDINGS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	30/12/22	AQ
China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask	29/12/22	AQ
China Pharma : Dec. 28, 2022_China Pharma Holdings, Inc. Announced the Launch of N95 Medical Pr	29/12/22	PU
China Pharma : Dec. 5, 2022_China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Di	06/12/22	PU
CHINA PHARMA HOLDINGS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	02/12/22	AQ
CHINA PHARMA HOLDINGS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	02/12/22	AQ
CHINA PHARMA HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	14/11/22	AQ
CHINA PHARMA HOLDINGS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	30/09/22	AQ
CHINA PHARMA HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	11/08/22	AQ
China Pharma : Announces Receipt of Noncompliance Notice from NYSE American - Form 8-K	23/06/22	PU
CHINA PHARMA HOLDINGS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	22/06/22	AQ
CHINA PHARMA HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	12/05/22	AQ
CHINA PHARMA HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	30/03/22	AQ
China Pharma : Submission of Matters to a Vote of Security Holders - Form 8-K	29/12/21	PU
CHINA PHARMA HOLDINGS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	29/12/21	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases China Pharma Holdings, Inc.

Equities

CPHI

US16941T3023

Press Releases

Filters